| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.13 | 6e-05 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.15 | 8e-05 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0001 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.28 | 0.0003 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |